SSA
APVO icon

Schonfeld Strategic Advisors’s Aptevo Therapeutics APVO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio APVO Stock Details APVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Hold
0
– -$28.8K – 2051
2023
Q4 		– Hold
0
– – – 1689
2023
Q3 		– Hold
0
– – – 1540
2023
Q2 		– Hold
0
– – – 1539
2023
Q1 		– Hold
0
– – – 1383
2022
Q4 		– Hold
0
– – – 1747
2022
Q3 		– Hold
0
– – – 1830
2022
Q2 		– Hold
0
– – – 1340
2022
Q1 		– Hold
0
– – – 1064
2021
Q4 		– Hold
0
– – – 839
2021
Q2 		– Hold
0
– -$296K – 1921
2021
Q1 		– Hold
0
– – – 1330
2020
Q4 		– Hold
0
– – – 1107

Other funds holding APVO

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
TC
Truvestments Capital Sarasota, Florida $554M AUM 32.49% 1-Year Est. Return